OUTCOMES WITH INFLIXIMAB AND ITS BIOSIMILARS IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA): REAL-WORLD EXPERIENCE IN THE US

被引：0
|
作者：
Helfgott, S. M. [1 ]
Radtchenko, J. [2 ]
Soloman, N. [3 ]
Huston, K. [4 ]
Singh, J. A. [5 ]
Edgerton, C. [6 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Trio Hlth, Louisville, CO USA
[3] Arizona Arthrit & Rheumatol Associates, Phoenix, AZ USA
[4] Ctr Rheumat Dis & Allergy Immunol, Kansas City, MO USA
[5] Univ Alabama Birmingham, Birmingham, AL USA
[6] Articularis Healthcare, Summerville, SC USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI4
引用
收藏
页码：S14 / S15
页数：2
相关论文
共 50 条
  • [1] Real-World Utilization of Biosimilars for Management of Rheumatoid Arthritis (RA) in the US
    Radtchenko, Janna
    Smith, Yolaine
    Kish, Jonathan
    Feinberg, Bruce
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] Real-World Utilization of Infliximab (IFX) and Its Biosimilars in Patients (Pts) with Rheumatoid Arthritis (RA) Since the First Biosimilar Approval in the US
    Helfgott, Simon
    Radtchenko, Janna
    Soloman, Nehad
    Huston, Kent Kwas
    Singh, Jasvinder
    Edgerton, Colin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [3] Real-world switching and discontinuation outcomes of infliximab biosimilars in patients with rheumatoid arthritis: A scoping review
    Yin, Yue
    McDermott, Cara
    Lockhart, Catherine
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (09): : 985 - 998
  • [4] Rheumatoid Arthritis Real-World Data on Biosimilars
    Walter, Monika
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2020, 117 (33-34): : A1566 - A1566
  • [5] Effectiveness of infliximab in patients with rheumatoid arthritis 'real world' experience
    Barr, SG
    Steber, W
    Kindopp-Bugo, K
    Martin, L
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (08) : 1876 - 1876
  • [6] Real-World DMARD Experience and Outcomes for Rheumatoid Arthritis Patients in Japan: Safety
    Kishimoto, Mitsumasa
    Tanaka, Yoshiya
    Harrold, Leslie
    Onofrei, Alina
    Barr, Christine
    Agarwal, Ekta
    Rivas, Jose L.
    Sugiyama, Naonobu
    Greenberg, Jeffrey
    Yamanaka, Hisashi
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [7] Real-World DMARD Experience and Outcomes for Rheumatoid Arthritis Patients in Japan: Effectiveness
    Tanaka, Yoshiya
    Yamanaka, Hisashi
    Harrold, Leslie
    Lin, Tin-chi
    Agarwal, Ekta
    Rivas, Jose L.
    Sugiyama, Naonobu
    Greenberg, Jeffrey
    Kishimoto, Mitsumasa
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] Outcomes in Real-World Patients with Early Aggressive Rheumatoid Arthritis
    Knapp, Keith
    Mueller, Eric
    Craig, Gary
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [9] ARE BIOSIMILARS EQUIVALENT TO ORIGINATOR MOLECULES IN THE REAL-WORLD? ASSESSMENTS OF EFFICACY, TOXICITY, AND TOLERABILITY OF INFLIXIMABS IN INFLIXIMAB-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS
    Edgerton, C.
    Adams, C.
    Frick, A.
    Helfgott, S. M.
    Huston, K.
    Milligan, S.
    Singh, J. A.
    Soloman, N.
    VALUE IN HEALTH, 2023, 26 (06) : S43 - S43
  • [10] Real-world Effectiveness of Infliximab in the Treatment of Rheumatoid Arthritis over 5 Years: The Canadian Experience
    Choquette, Denis
    Bensen, William
    Chow, Andrew
    Sheriff, Maqbool
    Kelsall, John
    Rodrigues, Jude
    Rampakakis, Emmanouil
    Sampalis, John
    Shawi, May
    Nantel, Francois
    Otawa, Susan
    Lehman, Allen
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 965 - 965
12345